The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
Resource Type
Abstract
Authors
Horwitz, Steven M. ; O'Connor, Owen A. ; Pro, Barbara ; Illidge, Tim ; Iyer, Swami P. ; Advani, Ranjana ; Bartlett, Nancy L. ; Christensen, Jacob Haaber ; Morschhauser, Franck ; Domingo-Domenech, Eva ; Rossi, Giuseppe ; Kim, Won Seog ; Feldman, Tatyana A. ; Menne, Tobias ; Belada, David ; Illés, Árpád ; Tobinai, Kensei ; Tsukasaki, Kunihiro ; Yeh, Su-Peng ; Shustov, Andrei R ; Hüttmann, Andreas ; Savage, Kerry J. ; Yuen, Sam ; Zinzani, Pier Luigi ; Miao, Harry ; Bunn, Veronica ; Fenton, Keenan ; Fanale, Michelle A. ; Puhlmann, Markus ; Truemper, Lorenz
Source
In Blood 5 November 2020 136 Supplement 1:3-5
Subject
Language
ISSN
0006-4971